UK becomes first country to authorize Pfizer/BioNTech’s Covid-19 vaccine (regulatory approval)

Details

Information about the COVID-19 vaccine, approved by MHRA on 2 December 2020.

The Information for healthcare professionals document is a description of a medicinal product’s properties and the conditions attached to its use. It explains how to use and prescribe a medicine. It is used by healthcare professionals, such as doctors, nurses and pharmacists.

The Information for UK recipients document provides information for patients on using the medicine safely. This is based on the Information for healthcare professionals of the product.

Find out more about the approval from our press release.

Ingredients

The Medicines and Healthcare products Agency can confirm that the Pfizer/BioNTech COVID-19 vaccine does not contain any components of animal origin.

A full list of ingredients for the qualitative and quantitative composition of the vaccine can be found at point 2 in the Information for Healthcare Professionals on Pfizer/BioNtech Vaccine.

A full list of ingredients for the excipient composition of the vaccine can be found at point 6 in the Information for Healthcare Professionals on Pfizer/BioNtech Vaccine.

A full list of ingredients for the qualitative and quantitative composition of the vaccine and a full list of the excipient composition of the vaccine can be found at point 6 in the Information for Recipients of the Pfizer/BioNtech Vaccine.

READ full here:
Information for healthcare professionals and the public about the Pfizer/BioNTech vaccine.